Sargent takes ASMI to battle
December 13, 2012
THE Australian Self-Medication
Industry has elected Mark Sargent,
General Manager, Australia & New
Zealand, Consumer Care, Bayer,
Australia, as its new President.
Sargent comes to the position
with 15 years worth of experience
in senior marketing, sales and
management roles, including 10
years in the over-the-counter
medicines sector in Australia and
globally.
He also has a MBA from the
Australian Graduate School of
Management and a Bachelor of
Commerce (Marketing) from the
University of NSW.
“I would like to congratulate Mark
Sargent on assuming the role of
President of ASMI,” said Executive
Director of ASMI, Dr Deon
Schoombie.
“He is an extremely experienced
senior executive with a deep
understanding of the industry.
“I am delighted that we will have
the benefit of one of our most
accomplished executives to help
guide our future direction at this
critical time,” Schoombie added.
Prior to his Presidential
appointment, Sargent served as an
active member of the ASMI
Committee of Management, and
Chair of the Self Care sub-committee.
Speaking about the future for
ASMI, Sargent said “There are a
number of key policy and
regulatory issues that will be
extremely important for the
industry over the coming year”.
“These include business reform at
the TGA, reviews into medicines
labelling and packaging, a new
trans-Tasman regulatory model,
reform of complementary
medicines, fresh approaches to
medicines scheduling and
promotion, and the advancement
of consumer self care,” he added.
MEANWHILE ASMI has also
appointed Ralf Dahmen, Managing
Director, Omega Pharma Australia
& New Zealand, as its new Vice
President (Secretary); and has also
re-elected Trevor Norman, General
Manager, Combe Asia-Pacific, as its
Vice President (Treasurer).
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Dec 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Dec 12
